Cargando…

High Density Lipoproteins and Diabetes

Epidemiological studies have established that a high plasma high density lipoprotein cholesterol (HDL-C) level is associated with reduced cardiovascular risk. However, recent randomised clinical trials of interventions that increase HDL-C levels have failed to establish a causal basis for this relat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cochran, Blake J., Ong, Kwok-Leung, Manandhar, Bikash, Rye, Kerry-Anne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8069617/ https://www.ncbi.nlm.nih.gov/pubmed/33918571 http://dx.doi.org/10.3390/cells10040850

Ejemplares similares

Role of High‐Density Lipoproteins in Cholesterol Homeostasis and Glycemic Control
por: Manandhar, Bikash, et al.
Publicado: (2019)

Relationship of High‐Density Lipoprotein Cholesterol With Renal Function in Patients Treated With Atorvastatin
por: Ong, Kwok Leung, et al.
Publicado: (2018)

High-Density Lipoprotein-Associated miR-223 Is Altered after Diet-Induced Weight Loss in Overweight and Obese Males
por: Tabet, Fatiha, et al.
Publicado: (2016)

High density lipoprotein-associated miRNA is increased following Roux-en-Y gastric bypass surgery for severe obesity
por: Ho, Jan Hoong, et al.
Publicado: (2021)

Statin Prescription Patterns and Associations with Subclinical Inflammation
por: Kadappu, Preetham, et al.
Publicado: (2022)

Altered High Density Lipoprotein Composition in Behavioral Variant Frontotemporal Dementia
por: Kim, Woojin Scott, et al.
Publicado: (2018)

The Role of High-Density Lipoproteins in Diabetes and Its Vascular Complications
por: Wong, Nathan K. P., et al.
Publicado: (2018)

High-Density Lipoproteins and the Kidney
por: Strazzella, Arianna, et al.
Publicado: (2021)

High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity
por: Denimal, Damien, et al.
Publicado: (2023)

The Causes and Consequences of Low Levels of High Density Lipoproteins in Patients with Diabetes
por: Barter, Philip J.
Publicado: (2011)

Fibroblast growth factor 21 in heart failure
por: Tucker, William, et al.
Publicado: (2022)

High density lipoproteins improve insulin sensitivity in high-fat diet-fed mice by suppressing hepatic inflammation
por: McGrath, Kristine C., et al.
Publicado: (2014)

High Density Lipoprotein: A Therapeutic Target in Type 2 Diabetes
por: Barter, Philip J.
Publicado: (2013)

High-Density Lipoproteins in Kidney Disease
por: Kon, Valentina, et al.
Publicado: (2021)

High-Density Lipoproteins Are Bug Scavengers
por: Meilhac, Olivier, et al.
Publicado: (2020)

Impact of High-Density Lipoproteins on Sepsis
por: De Geest, Bart, et al.
Publicado: (2022)

The Role of High-Density Lipoproteins in Endothelial Cell Metabolism and Diabetes-Impaired Angiogenesis
por: Primer, Khalia R., et al.
Publicado: (2020)

Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein
por: Itabe, Hiroyuki, et al.
Publicado: (2021)

The Role of High Density Lipoproteins in Thrombosis
por: Cuchel, Marina, et al.
Publicado: (2002)

High-Density Lipoproteins and the Immune System
por: Kaji, Hidesuke
Publicado: (2013)

High-density lipoprotein cholesterol: How High
por: Rajagopal, G., et al.
Publicado: (2012)

Utility of Non-High-Density Lipoprotein Cholesterol to High-Density Lipoprotein Cholesterol Ratio in Evaluating Incident Diabetes Risk
por: Sheng, Guotai, et al.
Publicado: (2022)

Nanobiotechnology applications of reconstituted high density lipoprotein
por: Ryan, Robert O
Publicado: (2010)

High density lipoproteins and atherosclerosis: emerging aspects
por: Sala, Federica, et al.
Publicado: (2012)

Proprotein convertases in high-density lipoprotein metabolism
por: Choi, Seungbum, et al.
Publicado: (2013)

High density lipoprotein mimicking nanoparticles for atherosclerosis
por: Chen, Jun, et al.
Publicado: (2020)

Impact of Reperfusion on Temporal Immune Cell Dynamics After Myocardial Infarction
por: Zhang, Richard Ying Ke, et al.
Publicado: (2023)

The Alcohol–High-Density Lipoprotein Athero-Protective Axis
por: Rosales, Corina, et al.
Publicado: (2020)

Cholesteryl ester transfer protein inhibitors: from high-density lipoprotein cholesterol to low-density lipoprotein cholesterol lowering agents?
por: Nurmohamed, Nick S, et al.
Publicado: (2021)

High-Density Lipoprotein and Prostate Cancer: An Overview
Publicado: (2013)

Revealing the Role of High-Density Lipoprotein in Colorectal Cancer
por: Zeljkovic, Aleksandra, et al.
Publicado: (2021)

High density lipoproteins and oxidative stress in breast cancer
por: Mazzuferi, Gabriele, et al.
Publicado: (2021)

Current Understanding of the Immunomodulatory Activities of High-Density Lipoproteins
por: Trakaki, Athina, et al.
Publicado: (2021)

Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research
por: Kornmueller, Karin, et al.
Publicado: (2019)

High-Density Lipoproteins as Homeostatic Nanoparticles of Blood Plasma
por: Kudinov, Vasily A., et al.
Publicado: (2020)

High-Density Lipoprotein-Targeted Therapies for Heart Failure
por: Mishra, Mudit, et al.
Publicado: (2020)

High-Density Lipoproteins: A Role in Inflammation in COPD
por: Kotlyarov, Stanislav
Publicado: (2022)

Inclisiran, Low-Density Lipoprotein Cholesterol and Lipoprotein (a)
por: Katsiki, Niki, et al.
Publicado: (2023)

Use of High-Refractive Index Hydrogels and Tissue Clearing for Large Biological Sample Imaging
por: Richardson, Alexander, et al.
Publicado: (2022)

Current status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy
por: Lin, Yun, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_kp1kvt12rhbcnqffnir6v96ov5